Wed, Sep 17, 2014, 12:25 AM EDT - U.S. Markets open in 9 hrs 5 mins


% | $
Quotes you view appear here for quick access.

Athersys, Inc. Message Board

  • market_ace market_ace Apr 21, 2014 9:44 AM Flag

    We're a #5 per Zacks !!

    I continue to be both humored and amazed by the fact that Zacks continues to issue #5 (Strong Sell) ratings on ATHX and other small biotechs. We got another one today. If you look at the criteria (Earnings, EPS Growth, PE, etc.) it makes absolutely no sense to even be evaluating a

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • It makes no difference to me what sacks says.Many of the best investments will be names you won't know very well like ATHX .Most investors on this board were able to find and recognize good information . The AVERAGE advisory service at times could be a source of losing advice.I'm selling at $676.00 JMO

      Sentiment: Strong Buy

    • Nevertheless, Zacks can be a pretty good contrarian indicator. As soon as they designated that #5 rating I figured that not long after, ATHX would begin rebounding. Then Zacks would produce some rationalizing commentary, a stage we haven't quite reached yet but will probably get to once Athersys blows past 3, which'll be this week I hope.

1.33-0.01(-0.75%)Sep 16 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.